Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +16.47% | +13.84% | +240.52% |
01:46pm | Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study | MT |
May. 14 | Transcript : Ocugen, Inc., Q1 2024 Earnings Call, May 14, 2024 |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.